---
schema_version: "secwatch.filing_event.v1"
accession: "0000914475-23-000047"
form_type: "8-K"
ticker: "NBIX"
cik: "0000914475"
company_name: "NEUROCRINE BIOSCIENCES INC"
filed_at: "2023-07-12T23:59:59+00:00"
generated_at: "2026-06-13T09:41:55.461667+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Neurocrine appoints Christine Poon to board; bylaws amended to increase board to 10

## Summary
- Christine A. Poon appointed as Class I director effective July 11, 2023, term until 2024 annual meeting.
- Poon receives $60k annual cash retainer and option for 16,375 shares (~$800k Black-Scholes) vesting over 3 years.
- Board size increased from 9 to 10 via amendment to Section 3.2 of Bylaws.
- Poon previously served as Vice Chairman of Johnson & Johnson and Dean at Ohio State Fisher College of Business.

## SEC filing metadata
- accession: 0000914475-23-000047
- form_type: 8-K
- ticker: NBIX
- cik: 0000914475
- company_name: NEUROCRINE BIOSCIENCES INC
- filed_at: 2023-07-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/914475/000091447523000047/0000914475-23-000047-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/914475/000091447523000047/nbix-20230711.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000914475-23-000047
- JSON: https://secwatch.observer/filing/0000914475-23-000047.json
- Plain text: https://secwatch.observer/filing/0000914475-23-000047.txt

## Key facts
- Executive change
  Christine A. Poon was appointed as Director at NEUROCRINE BIOSCIENCES INC.
  - Action: appointed
  - Role: Director
  source text: On July 11, 2023, the Board of Directors (the “Board”) of Neurocrine Biosciences, Inc., a Delaware corporation (“Neurocrine”), upon the recommendation of its Nominating / Corporate Governance Committee, appointed Christine A. Poon as a member of the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/914475/000091447523000047/0000914475-23-000047-index.htm
- Governance Changes
  NEUROCRINE BIOSCIENCES INC: Amended Section 3.2 of Bylaws to increase board size from nine to ten members (effective 2023-07-11).
  - Change: bylaw amendment
  - Effective: 2023-07-11
  source text: On July 11, 2023, the Board amended Section 3.2 of Neurocrine’s Bylaws, as amended and restated (the “Bylaws”), to provide that the Board shall consist of ten members.
  evidence_url: https://www.sec.gov/Archives/edgar/data/914475/000091447523000047/0000914475-23-000047-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.